Header Logo

Connection

John Somberg to Anti-Arrhythmia Agents

Back to Details
This is a "connection" page, showing publications John Somberg has written about Anti-Arrhythmia Agents.
John Somberg
Connection Strength
6.858
Anti-Arrhythmia Agents
  1. The Bretylium Saga: A Novel "Old Drug" for Cardiac Resuscitation. Am J Cardiol. 2020 05 15; 125(10):1596-1598.
    View in: PubMed
    Score: 0.698
  2. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
    View in: PubMed
    Score: 0.359
  3. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72.
    View in: PubMed
    Score: 0.357
  4. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82.
    View in: PubMed
    Score: 0.305
  5. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008; 110(3):145-52.
    View in: PubMed
    Score: 0.299
  6. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide. Cardiology. 2008; 110(3):209-16.
    View in: PubMed
    Score: 0.299
  7. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation. Am J Ther. 2007 May-Jun; 14(3):269-76.
    View in: PubMed
    Score: 0.286
  8. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007; 108(1):18-27.
    View in: PubMed
    Score: 0.274
  9. Letter from Konstantinos P. Letsas et al. - invited editorial comment. Cardiology. 2006; 105(3):148.
    View in: PubMed
    Score: 0.262
  10. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22.
    View in: PubMed
    Score: 0.249
  11. The influence of extracellular acidosis on the effect of IKr blockers. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):67-76.
    View in: PubMed
    Score: 0.247
  12. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV. Am J Ther. 2005 Jan-Feb; 12(1):9-16.
    View in: PubMed
    Score: 0.244
  13. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004 Mar 01; 93(5):576-81.
    View in: PubMed
    Score: 0.230
  14. The quest for an aqueous amiodarone. Am J Ther. 2003 Nov-Dec; 10(6):458-61.
    View in: PubMed
    Score: 0.225
  15. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2020 Feb; 41(2):418-422.
    View in: PubMed
    Score: 0.170
  16. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60.
    View in: PubMed
    Score: 0.137
  17. Adverse Reactions of Amiodarone on the Thyroid. Cardiology. 2016; 134(3):364-5.
    View in: PubMed
    Score: 0.133
  18. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J. 1994 Sep; 128(3):575-85.
    View in: PubMed
    Score: 0.119
  19. New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7.
    View in: PubMed
    Score: 0.084
  20. Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35.
    View in: PubMed
    Score: 0.074
  21. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
    View in: PubMed
    Score: 0.073
  22. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
    View in: PubMed
    Score: 0.073
  23. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
    View in: PubMed
    Score: 0.072
  24. Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5.
    View in: PubMed
    Score: 0.068
  25. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.067
  26. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6.
    View in: PubMed
    Score: 0.066
  27. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
    View in: PubMed
    Score: 0.066
  28. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36.
    View in: PubMed
    Score: 0.063
  29. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7.
    View in: PubMed
    Score: 0.062
  30. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33.
    View in: PubMed
    Score: 0.062
  31. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
    View in: PubMed
    Score: 0.062
  32. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48.
    View in: PubMed
    Score: 0.061
  33. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27.
    View in: PubMed
    Score: 0.061
  34. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.
    View in: PubMed
    Score: 0.061
  35. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
    View in: PubMed
    Score: 0.061
  36. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43.
    View in: PubMed
    Score: 0.060
  37. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog. J Clin Pharmacol. 1984 Oct; 24(10):466-72.
    View in: PubMed
    Score: 0.060
  38. New directions in antiarrhythmic drug therapy. Am J Cardiol. 1984 Aug 13; 54(4):8B-17B.
    View in: PubMed
    Score: 0.059
  39. New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainide. Am J Cardiol. 1984 Aug 13; 54(4):1B.
    View in: PubMed
    Score: 0.059
  40. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
    View in: PubMed
    Score: 0.059
  41. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
    View in: PubMed
    Score: 0.059
  42. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B.
    View in: PubMed
    Score: 0.059
  43. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7.
    View in: PubMed
    Score: 0.059
  44. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43.
    View in: PubMed
    Score: 0.058
  45. Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies. Am J Ther. 2002 Jan-Feb; 9(1):19-24.
    View in: PubMed
    Score: 0.050
  46. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80.
    View in: PubMed
    Score: 0.045
  47. Inhibition of Human Ether-A-Go-Go-Related Gene (hERG) Potassium Current by the Novel Sotalol Analogue, Soestalol. JACC Clin Electrophysiol. 2020 07; 6(7):756-759.
    View in: PubMed
    Score: 0.045
  48. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6.
    View in: PubMed
    Score: 0.041
  49. Successful heart failure therapy is effective antiarrhythmia therapy. Am Heart J. 1996 May; 131(5):1048-50.
    View in: PubMed
    Score: 0.033
  50. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F.
    View in: PubMed
    Score: 0.018
  51. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.016
  52. The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24.
    View in: PubMed
    Score: 0.016
  53. Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
    View in: PubMed
    Score: 0.015
  54. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.